Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
BMC Neurosci ; 19(Suppl 1): 12, 2018 04 19.
Artículo en Inglés | MEDLINE | ID: mdl-29745855

RESUMEN

Optogenetics has become widely recognized for its success in real-time control of brain neurons by utilizing non-mammalian photosensitive proteins to open or close membrane channels. Here we review a less well known type of optogenetic constructs that employs photosensitive proteins to transduce the signal to regulate gene transcription, and its possible use in medicine. One of the problems with existing gene therapies is that they could remain active indefinitely while not allowing regulated transgene production on demand. Optogenetic regulation of transcription (ORT) could potentially be used to regulate the production of a biological drug in situ, by repeatedly applying light to the tissue, and inducing expression of therapeutic transgenes when needed. Red and near infrared wavelengths, which are capable of penetration into tissues, have potential for therapeutic applications. Existing ORT systems are reviewed herein with these considerations in mind.


Asunto(s)
Optogenética/métodos , Activación Transcripcional , Animales , Encéfalo/metabolismo , Terapia Genética , Humanos , Luz , Neuronas/metabolismo , Transducción de Señal , Investigación Biomédica Traslacional
2.
Photomed Laser Surg ; 33(10): 498-503, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26398729

RESUMEN

OBJECTIVE: The purpose of this study was to investigate whether low-level light therapy (LLLT) was capable of modulating expression of ultraviolet (UV) light-responsive genes in vivo. MATERIALS AND METHODS: The effects of 670 nm light-emitting diode (LED) array irradiation were investigated in a hairless SHK-1 mouse epidermis model. Mice were given a single dose of UVA/UVB light, or three doses of red light (670 nm @ 8 mW/cm(2) x 312 sec, 2.5 J/cm(2) per session) spread over 24 h along with combinations of pre- and post-UV treatment with red light. Levels of 14 UV-responsive mRNAs were quantified 24 h after UV irradiation by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). RESULTS: The transcription of mRNAs encoding for cluster of differentiation molecule 11b (CD11b) (p < 0.05) and interferon (IFN)-γ (p < 0.012) increased after irradiation with red light alone, whereas expression level of cyclooxygenase (COX)-2 (p < 0.02) was downregulated. Genes unresponsive to UV did not change their expression levels after exposure to red light either. Pretreatment with red light significantly modified response of Fos to UV exposure (p < 0.01). A synergy of UV and post-treatment with red light in reducing the transcription levels of CD11b (p < 0.05) and inducible nitric oxide synthase (iNOS) (p < 0.05) was observed. CONCLUSIONS: This is an initial observation that in mouse red light LLLT more often than not causes opposite gene expression changes or reduces those caused by moderate UVA-UVB irradiation.


Asunto(s)
Epidermis/efectos de la radiación , Expresión Génica/efectos de la radiación , Terapia por Luz de Baja Intensidad , Rayos Ultravioleta/efectos adversos , Animales , Epidermis/química , Epidermis/metabolismo , Femenino , Ratones , Ratones Pelados , Proteínas Oncogénicas v-fos/análisis , Proteínas Oncogénicas v-fos/genética , Proteínas Oncogénicas v-fos/metabolismo
3.
Photomed Laser Surg ; 30(9): 551-8, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22853435

RESUMEN

OBJECTIVE: Red light phototherapy is known to stimulate cell proliferation in wound healing. This study investigated whether low-level light therapy (LLLT) would promote tumor growth when pre-existing malignancy is present. BACKGROUND DATA: LLLT has been increasingly used for numerous conditions, but its use in cancer patients, including the treatment of lymphedema or various unrelated comorbidities, has been withheld by practitioners because of the fear that LLLT might result in initiation or promotion of metastatic lesions or new primary tumors. There has been little scientific study of oncologic outcomes after use of LLLT in cancer patients. METHODS: A standard SKH mouse nonmelanoma UV-induced skin cancer model was used after visible squamous cell carcinomas were present, to study the effects of LLLT on tumor growth. The red light group (n=8) received automated full body 670 nm LLLT delivered twice a day at 5 J/cm(2) using an LED source. The control group (n=8) was handled similarly, but did not receive LLLT. Measurements on 330 tumors were conducted for 37 consecutive days, while the animals received daily LLLT. RESULTS: Daily tumor measurements demonstrated no measurable effect of LLLT on tumor growth. CONCLUSIONS: This experiment suggests that LLLT at these parameters may be safe even when malignant lesions are present. Further studies on the effects of photoirradiation on neoplasms are warranted.


Asunto(s)
Carcinoma de Células Escamosas/radioterapia , Terapia por Luz de Baja Intensidad/métodos , Neoplasias Cutáneas/radioterapia , Animales , Proliferación Celular/efectos de la radiación , Modelos Animales de Enfermedad , Diseño de Equipo , Terapia por Luz de Baja Intensidad/instrumentación , Ratones , Dosificación Radioterapéutica , Cicatrización de Heridas/efectos de la radiación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA